We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$4.32B
Cap. Flow
+$4.15B
Cap. Flow %
39.25%
Top 10 Hldgs %
26.92%
Holding
1,909
New
683
Increased
298
Reduced
275
Closed
491

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Consumer Discretionary 5.98%
3 Communication Services 3.46%
4 Healthcare 1.95%
5 Financials 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHV icon
1426
CALL
Achieve Life Sciences
ACHV
$659M
-41,400
Closed -$196K
ACLX
1427
DELISTED
Arcellx
ACLX
-37,580
Closed -$3.25M
ACM icon
1428
Aecom
ACM
$9.3B
-3,600
Closed -$393K
AGEN
1429
Agenus
AGEN
$312M
-11,100
Closed -$60.8K
AGEN
1430
PUT
Agenus
AGEN
$312M
-20,000
Closed -$110K
AGO icon
1431
Assured Guaranty
AGO
$3.66B
-4,400
Closed -$350K
AJG icon
1432
CALL
Arthur J. Gallagher & Co
AJG
$64.1B
-15,000
Closed -$4.22M
AJG icon
1433
Arthur J. Gallagher & Co
AJG
$64.1B
-9,450
Closed -$2.66M
AKRO
1434
DELISTED
Akero Therapeutics
AKRO
-10,087
Closed -$289K
AKRO
1435
PUT
DELISTED
Akero Therapeutics
AKRO
-42,500
Closed -$1.22M
ALLY icon
1436
PUT
Ally Financial
ALLY
$13.2B
-20,000
Closed -$712K
ALNY icon
1437
Alnylam Pharmaceuticals
ALNY
$27.5B
-8,405
Closed -$2.21M
ALSN icon
1438
CALL
Allison Transmission
ALSN
$9.5B
-100,000
Closed -$9.61M
GOLD
1439
Gold.com Inc
GOLD
$1.2B
-28,000
Closed -$1.24M
APGE icon
1440
Apogee Therapeutics
APGE
$10.1B
-7,540
Closed -$385K
APGE icon
1441
PUT
Apogee Therapeutics
APGE
$10.1B
-200,000
Closed -$11.7M
APLS
1442
DELISTED
Apellis Pharmaceuticals
APLS
-216,006
Closed -$6.5M
APYX icon
1443
CALL
Apyx Medical
APYX
$173M
-282,600
Closed -$350K
ARE icon
1444
PUT
Alexandria Real Estate Equities
ARE
$8.97B
-10,000
Closed -$1.19M
ARGX icon
1445
PUT
argenx
ARGX
$53.4B
-47,100
Closed -$25.5M
ARRY icon
1446
Array Technologies
ARRY
$803M
-3,000
Closed -$19.8K
ARWR icon
1447
Arrowhead Research
ARWR
$11.9B
-7,900
Closed -$163K
ASND icon
1448
CALL
Ascendis Pharma A/S
ASND
$16B
-32,500
Closed -$4.85M
AVDL
1449
DELISTED
Avadel Pharmaceuticals
AVDL
-123,002
Closed -$1.49M
AVDL
1450
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
-521,600
Closed -$6.84M

Similar funds

Caption Management's Q4 2024 Portfolio in Review

As of Q4 2024, Caption Management held 1,909 positions worth $10.6B, up 69% from $6.27B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Caption Management deployed $4.15B of net new capital in Q4 2024, opening 683 new positions and adding to 298 existing holdings. Its largest new stake was NVIDIA: 4,060,000 shares worth $545M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P Regional Banking ETF, an estimated $63.1M trimmed.

  • Caption Management's largest Q4 2024 buy was NVIDIA: 4,060,000 shares worth $545M.
  • Caption Management added most to Alphabet (Google) Class C in Q4 2024, an estimated $121M increase.
  • Caption Management's biggest Q4 2024 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $63.1M.
  • Caption Management fully exited Broadcom in Q4 2024, selling an estimated $20.5M.
  • Caption Management's ten largest holdings make up 27% of its $10.6B portfolio in Q4 2024.
  • Caption Management opened 683 new positions and closed 491 in Q4 2024.
  • Caption Management's portfolio value rose 69% quarter-over-quarter to $10.6B.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.